Business / Finance

RSS

Teavana third quarter net sales increase 35% to $33.4 million

Teavana Holdings, Inc. today announced financial results for the third quarter and fiscal year-to-date ended October 30, 2011.

2 Dec 2011

GE Healthcare invests in C8 MediSensors to focus on disease management solutions

GE Capital and GE Healthcare, the financial services and healthcare divisions of General Electric Company, announced today an investment in C8 MediSensors, Inc., a privately held developer of non-invasive continuous glucose monitors for diabetic patients.

2 Dec 2011

Corning acquires Mediatech

Great Point Partners today announced that Great Point Partners I portfolio company, Mediatech, Inc., was acquired by Corning Incorporated in an all-cash transaction. Mediatech is now a wholly-owned subsidiary of Corning and will be integrated into Corning's Life Science segment.

2 Dec 2011

Global external defibrillators market to grow at 6% CAGR to exceed $2.2 billion by 2017

Global Information, Inc. (GII) presents "External Defibrillators - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017" by GlobalData.

2 Dec 2011

Bausch + Lomb announces acquisition of Pfortner Cornealent SACIF

Bausch + Lomb, the global eye health company, today announced it has acquired 100 percent of the outstanding shares of Laboratorio Pfortner Cornealent SACIF, the controlling entity of Waicon.

2 Dec 2011

Agilent expands life sciences business with two strategic acquisitions

Agilent Technologies Inc. today announced it is expanding its life sciences business with two strategic acquisitions.

2 Dec 2011

MergerTech launches $50M venture capital fund for healthcare IT

MergerTech Advisors is excited to announce the launch of 'MergerTech Capital', a new $50 million venture capital fund. The fund will focus on the investment and development of healthcare IT product and services firms, building on the sectors' substantial potential for extraordinary growth and creativity.

2 Dec 2011

Novelos prices underwritten public offering of $5,904,000 of common stock

Novelos Therapeutics, Inc., a pharmaceutical company developing novel drugs for treatment and diagnosis of cancer, today announced the pricing of an underwritten public offering of 9,840,000 units at $0.60 per unit for gross proceeds of $5,904,000.

2 Dec 2011

Pfizer acquires Ferrosan Consumer Health's business

Pfizer Inc. today announced that it has completed its previously announced acquisition of Ferrosan Consumer Health's business, which includes dietary supplements and lifestyle products, from Altor 2003 Fund GP Limited.

1 Dec 2011

Corning completes acquisition of Mediatech

Corning Incorporated announced today that it has completed the acquisition of Mediatech, Inc., a Virginia-based corporation, including Mediatech's subsidiary, KD Medical, Inc., a Maryland-based corporation.

1 Dec 2011

Lipitor going generic, Pfizer making deals to keep consumers

The popular cholesterol-lowering drug Lipitor goes off-patent today. Manufacturer Pfizer planned ahead, making agreements with some insurers to keep covering the drug.

1 Dec 2011

arGEN-X closes EUR 27.5 million Series B fundraising round

arGEN-X, a biopharmaceutical company focused on the discovery and development of human monoclonal antibodies from its proprietary SIMPLE Antibody platform, announced today the closing of a EUR 27.5 million (USD 37 million) Series B fundraising round, which was oversubscribed.

1 Dec 2011

Ranbaxy and Teva announce generic Lipitor agreement

Teva Pharmaceutical Industries Ltd. announced today that pursuant to an agreement between its subsidiary, Teva Pharmaceuticals USA, Inc. and Ranbaxy Laboratories Limited, a portion of the profits from Ranbaxy's sales of Atorvastatin Calcium Tablets during Ranbaxy's 180-day first-to-file exclusivity period, will be paid to Teva.

1 Dec 2011

Affymetrix signs definitive agreement to acquire eBioscience

Affymetrix, Inc., today announced that it has signed a definitive agreement to acquire eBioscience, Inc., a privately-held San Diego, CA-based company with an industry-leading position in flow cytometry and immunoassay reagents for immunology and oncology research and diagnostics. Under the terms of the agreement, Affymetrix will acquire eBioscience for $330 million in cash subject to certain customary adjustments.

30 Nov 2011

Associated Press examines Chinese vaccine makers' entry into international market

"China's vaccine makers are gearing up over the next few years to push exports in a move that should lower costs of lifesaving immunizations for the world's poor and provide major new competition for the big Western pharmaceutical companies," the Associated Press reports in a feature examining the entry of Chinese vaccine makers into the international market.

30 Nov 2011

BioLineRx reports third quarter net loss of NIS 7.9 million

BioLineRx Ltd., a biopharmaceutical development company, today reported its results for the third quarter ending September 30, 2011.

29 Nov 2011

IrriMax, Geo-Med partner to provide products to U.S. government facilities and the military

IrriMax Corporation announced today that Geo-Med, LLC, a Service-Disabled Veteran-Owned Small Business, will now be responsible for sales and distribution of the IrriSept product line to U.S. government facilities and the military marketplace.

28 Nov 2011

MRG releases 2012 report on US markets for ENT and bronchoscopy devices

According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, advances in procedures competing with functional endoscopic sinus surgery (FESS) and nasal packing devices will have a significant positive effect on the ear, nose and throat (ENT) device market in the United States over the next few years.

From Evident Corporation - Life Sciences 28 Nov 2011

Ansell purchases minority share of Yulex

Ansell Limited, a global leader in protection solutions, today announced it has purchased a minority share of Yulex Corporation, a manufacturer of biopolymers derived from guayule.

28 Nov 2011

ArthroCare reaches agreement in principle to settle private securities class action suits

ArthroCare Corp., a leader in developing state-of-the-art, minimally invasive surgical products, announced that it has reached an agreement in principle to settle the private securities class action suits pending against the Company and two of its former officers.

28 Nov 2011